Abstract
MicroRNAs (miRNAs) are short, single stranded, non-coding RNA molecules. They are produced by many different species and are key regulators of several physiological processes. miRNAs are also encoded by the genomes of multiple virus families, such as herpesvirus family. In particular, miRNAs from Epstein Barr virus were found at high concentrations in different associated pathologies, such as Burkitt’s lymphoma, Hodgkin disease, and nasopharyngeal carcinoma. Thanks to their stability, these molecules could possibly serve as biomarkers for EBV-associated diseases. In this study, a stem-loop real-time PCR for miR-BART2-5p, miR-BART15, and miR-BART22 EBV miRNAs detection and quantification has been developed. Evaluation of these miRNAs in 31 serum samples (12 from patients affected by primary immunodeficiency, 9 from X-linked agammaglobulinemia and 10 from healthy subjects) has been carried out. The amplification performance showed a wide dynamic range (108–102 copies/reaction) and sensibility equal to 102 copies/reaction for all the target tested. Serum samples analysis, on the other hand, showed a statistical significant higher level of miR-BART22 in primary immunodeficiency patients (P = 0.0001) compared to other groups and targets. The results confirmed the potential use of this assay as a tool for monitoring EBV-associated disease and for miRNAs expression profile analysis.
Similar content being viewed by others
References
Ghildiyal, M., & Zamore, P. D. (2009). Small silencing RNAs: an expanding universe. Nature Reviews Genetics, 10, 94–108.
Baltimore, D., Boldin, M. P., O’Connell, R. M., Rao, D. S., & Taganov, K. D. (2008). MicroRNAs: new regulators of immune cell development and function. Nature Immunology, 9, 839–845.
Ivey, K. N., & Srivastava, D. (2010). MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell, 7, 36–41.
Tili, E., Michaille, J. J., Costinean, S., & Croce, C. M. (2008). MicroRNAs, the immune system and rheumatic disease. Nature Clinical Practice Rheumatology, 4, 534–541.
Di Leva, G., & Croce, C. M. (2010). Roles of small RNAs in tumor formation. Trends in Molecular Medicine, 16, 257–267.
Du, L., & Pertsemlidis, A. (2011). Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation. Journal of Molecular Cell Biology, 3, 176–180.
Kincaid, R. P., & Sullivan, C. S. (2012). Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathogens, 8(12), e1003018.
Umbach, J. L., Nagel, M. A., Cohrs, R. J., Gilden, D. H., & Cullen, B. R. (2009). Analysis of human alpha herpesvirus microRNA expression in latently infected human trigeminal ganglia. Journal of Virology, 83, 10677–10683.
Harwig, A., Das, A. T., & Berkhout, B. (2015). HIV-1 RNAs: sense and antisense, large mRNAs and small siRNAs and miRNAs. Current Opinion in HIV and AIDS, 10, 103–109.
Umbach, J. L., Kramer, M. F., Jurak, I., Karnowski, H. W., Coen, D. M., & Cullen, B. R. (2008). MicroRNAs expressed by Herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature, 454, 780–783.
Bellare, P., & Ganem, D. (2009). Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host & Microbe, 6, 570–575.
Lei, X., Bai, Z., Ye, F., et al. (2010). Regulation of NF-κB inhibitor IκBα and viral replication by a KSHV microRNA. Nature Cell Biology, 12, 193–199.
Klinke, O., Feederle, R., & Delecluse, H. J. (2014). Genetics of Epstein-Barr virus microRNAs. Seminars in Cancer Biology, 26, 52–59.
Ferracin, M., Veronese, A., & Negrini, M. (2010). Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Review of Molecular Diagnostics, 10, 297–308.
Pfeffer, S., Zavolan, M., Grässer, F. A., Chien, M., Russo, J. J., Ju, J., et al. (2004). Identification of virus-encoded microRNAs. Science, 304, 734–736.
Gao, L., Ai, J., Xie, Z., Zhou, C., Liu, C., Zhang, H., & Shen, K. (2015). Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children. Virology Journal, 12, 208. doi:10.1186/s12985-015-0441-y.
Brase, J. C., Wuttig, D., Kuner, R., & Sultmann, H. (2010). Serum microRNAs as noninvasive biomarkers for cancer. Molecular Cancer, 9, 306–310.
Moussay, E., Wang, K., Cho, J. H., et al. (2011). MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 108, 6573–6578.
Lim, L. P., Glasner, M. E., Yekta, S., Burge, C. B., & Bartel, D. P. (2003). Vertebrate microRNA genes. Science, 299, 1540–1545.
Liang, R. Q., Li, W., Li, Y., et al. (2005). An oligonucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe. Nucleic Acids Research, 33, e17.
Chen, C., Ridzon, D. A., Broomer, A. J., et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research, 33, e179.
Yao, Y., Nellåker, C., & Karlsson, H. (2006). Evaluation of minor groove binding probe and Taqman probe PCR assays: Influence of mismatches and template complexity on quantification. Molecular and Cellular Probes, 20, 311–316.
Geha, R. S., Notarangelo, L. D., Casanova, J. L., et al. (2007). Primary immunodeficiency diseases: an update from the international union of immunological societies primary immunodeficiency diseases classification committee. Journal of Allergy and Clinical Immunology, 120, 776–794.
Bergallo, M., Gambarino, S., Martino, S., et al. (2015). Comparison of two available RNA extraction protocols for microRNA amplification in serum samples. Journal of Clinical Laboratory Analysis. doi:10.1002/jcla.21848.
Huang, P. C., Chen, C. Y., Yang, F. Y., & Au, L. C. (2009). A multisampling reporter system for monitoring microRNA activity in the same population of cells. BioMed Research International, 10, 471–476.
Giulietti, A., Overbergh, L., Valckx, D., et al. (2001). An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods, 25, 386–401.
Kawano, Y., Iwata, S., Kawada, J., et al. (2013). Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection. Journal of Infectious Diseases, 208, 771–779.
Barth, S., Pfuhl, T., Mamiani, A., et al. (2008). Epstein-Barr virus-encoded micro- RNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Research, 36, 666–675.
Nachmani, D., Stern-Ginossar, N., Sarid, R., & Mandelboim, O. (2009). Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host & Microbe, 5, 376–385.
Choy, E. Y., Siu, K. L., Kok, K. H., et al. (2008). An Epstein-Barr virus-encoded micro- RNA targets PUMA to promote host cell survival. Journal of Experimental Medicine, 205, 2551–2560.
Lung, R. W., Tong, J. H., Sung, Y. M., et al. (2009). Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia, 11, 1174–1184.
Amoroso, R., Fitzsimmons, L., Thomas, W. A., Kelly, G. L., Rowe, M., & Bell, A. I. (2011). Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. Journal of Virology, 85, 996–1010. doi:10.1128/JVI.01528-10.
Chan, J. Y., Gao, W., Ho, W. K., Wei, W. I., & Wong, T. S. (2012). Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma. Anticancer Research, 32, 3201–3210.
Cohen, J. I. (2000). Epstein-Barr virus infection. New England Journal of Medicine, 343, 481–492.
Xia, T., O’Hara, A., Araujo, I., et al. (2008). EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-miR-BHRF1–3. Cancer Research, 68, 1436–1442.
Xing, L., & Kieff, E. (2007). Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. Journal of Virology, 81, 9967–9975.
Pratt, Z. L., Kuzembayeva, M., Sengupta, S., & Sugden, B. (2009). The microRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell lines. Virology, 386, 387–397.
Yuan, J., Cahir-McFarland, E., Zhao, B., & Kieff, E. (2006). Virus and cell RNAs expressed during Epstein-Barr virus replication. Journal of Virology, 80, 2548–2565.
Cai, X., Schafer, A., Lu, S., Bilello, J. P., Desrosiers, R. C., Edwards, R., et al. (2006). Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog, 2, e23. doi:10.1371/journal.ppat.0020023.
Cameron, J. E., Fewell, C., Yin, Q., McBride, J., Wang, X., Lin, Z., et al. (2008). Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology, 382, 257–266. doi:10.1016/j.virol.2008.09.018.
Acknowledgments
The authors thank the colleagues of the Department of Public Health and Pediatrics. The study was sponsored by Fondazione Giovanni Goria.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergallo, M., Merlino, C., Montin, D. et al. Development of a Low-Cost Stem-Loop Real-Time Quantification PCR Technique for EBV miRNA Expression Analysis. Mol Biotechnol 58, 540–550 (2016). https://doi.org/10.1007/s12033-016-9951-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-016-9951-0